{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:08:42Z","timestamp":1792796922188,"version":"4.5.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003841","name":"Ilam University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003841","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.ejps.2021.105837","type":"journal-article","created":{"date-parts":[[2021,4,6]],"date-time":"2021-04-06T11:20:41Z","timestamp":1617708041000},"page":"105837","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Development of a chimeric vaccine candidate based on Toxoplasma gondii major surface antigen 1 and apicoplast proteins using comprehensive immunoinformatics approaches"],"prefix":"10.1016","volume":"162","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4005-2687","authenticated-orcid":false,"given":"Ali","family":"Asghari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadegh","family":"Shamsinia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan","family":"Nourmohammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamidreza","family":"Majidiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Fatollahzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taher","family":"Nemati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid","family":"Irannejad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid Reza","family":"Nouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ezatollah","family":"Ghasemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morteza","family":"Shams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ejps.2021.105837_bib0001","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1017\/S0031182019001318","article-title":"A review of toxoplasmosis in humans and animals in Turkey","volume":"147","author":"Kol\u00f6ren","year":"2020","journal-title":"Parasitology"},{"key":"10.1016\/j.ejps.2021.105837_bib0002","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/S0140-6736(04)16412-X","article-title":"Toxoplasmosis","volume":"365","author":"Montoya","year":"2004","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.ejps.2021.105837_bib0003","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1128\/CMR.05013-11","article-title":"Epidemiology of and diagnostic strategies for toxoplasmosis","volume":"25","author":"Robert-Gangneux","year":"2012","journal-title":"Clin. Microbiol. Rev."},{"issue":"4","key":"10.1016\/j.ejps.2021.105837_bib0004","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00057-17","article-title":"Treatment of toxoplasmosis: historical perspective, animal models, and current clinical practice","volume":"31","author":"Dunay","year":"2018","journal-title":"Clin. Microbiol. Rev."},{"issue":"3","key":"10.1016\/j.ejps.2021.105837_bib0005","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.pt.2019.01.005","article-title":"Advances in the development of anti-Toxoplasma gondii vaccines: challenges, opportunities, and perspectives","volume":"35","author":"Wang","year":"2019","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.ejps.2021.105837_bib0006","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.micpath.2018.11.003","article-title":"A systematic review of Toxoplasma gondii antigens to find the best vaccine candidates for immunization","volume":"126","author":"Rezaei","year":"2019","journal-title":"Microb. Pathog."},{"issue":"1","key":"10.1016\/j.ejps.2021.105837_bib0007","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1600-065X.2010.00992.x","article-title":"Immunology of Toxoplasma gondii","volume":"240","author":"Munoz","year":"2011","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.ejps.2021.105837_bib0008","series-title":"Toxoplasma gondii: the Model apicomplexan. Perspectives and Methods","author":"Weiss","year":"2011"},{"key":"10.1016\/j.ejps.2021.105837_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.cimid.2020.101414","article-title":"Toxoplasma gondii surface antigen 1 (SAG1) as a potential candidate to develop vaccine against toxoplasmosis: a systematic review","volume":"69","author":"Pagheh","year":"2020","journal-title":"Comp. Immunol. Microbiol. Infect. Dis."},{"key":"10.1016\/j.ejps.2021.105837_bib0010","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1042\/bse0510111","article-title":"The apicoplast: a red alga in human parasites","volume":"51","author":"Docampo","year":"2011","journal-title":"Essays Biochem."},{"issue":"2\u20133","key":"10.1016\/j.ejps.2021.105837_bib0011","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ijpara.2016.08.005","article-title":"The apicoplast: now you see it, now you don\u2019t","volume":"47","author":"McFadden","year":"2017","journal-title":"Int. J. Parasitol."},{"issue":"1","key":"10.1016\/j.ejps.2021.105837_bib0012","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1462399401002204","article-title":"Toxoplasma gondii genomics: shedding light on pathogenesis and chemotherapy","volume":"3","author":"Ajioka","year":"2001","journal-title":"Expert Rev. Mol. Med."},{"issue":"8","key":"10.1016\/j.ejps.2021.105837_bib0013","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1007\/s00018-011-0646-1","article-title":"The apicomplexan plastid and its evolution","volume":"68","author":"Sato","year":"2011","journal-title":"Cellular and Molecular Life Sci."},{"key":"10.1016\/j.ejps.2021.105837_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiolchem.2019.107158","article-title":"Do Toxoplasma gondii apicoplast proteins have antigenic potential? An in silico study","volume":"84","author":"Can","year":"2020","journal-title":"Comput. Biol. Chem."},{"issue":"4","key":"10.1016\/j.ejps.2021.105837_bib0015","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1038\/nm1218","article-title":"The process development challenge for a new vaccine","volume":"11","author":"Buckland","year":"2005","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.ejps.2021.105837_bib0016","doi-asserted-by":"crossref","first-page":"241","DOI":"10.4161\/hv.26687","article-title":"Computer-aided vaccine design","volume":"10","author":"Flower","year":"2014","journal-title":"Hum. Vaccin. Immunother."},{"issue":"3","key":"10.1016\/j.ejps.2021.105837_bib0017","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s00726-006-0485-9","article-title":"Prediction of linear B-cell epitopes using amino acid pair antigenicity scale","volume":"33","author":"Chen","year":"2007","journal-title":"Amino Acids"},{"issue":"9","key":"10.1016\/j.ejps.2021.105837_bib0018","doi-asserted-by":"crossref","first-page":"e45152","DOI":"10.1371\/journal.pone.0045152","article-title":"SVMTriP: a method to predict antigenic epitopes using support vector machine to integrate tri-peptide similarity and propensity","volume":"7","author":"Yao","year":"2012","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.ejps.2021.105837_bib0019","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/prot.21078","article-title":"Prediction of continuous B-cell epitopes in an antigen using recurrent neural network","volume":"65","author":"Saha","year":"2006","journal-title":"Proteins: Structure, Function, and Bioinformatics"},{"key":"10.1016\/j.ejps.2021.105837_bib0020","series-title":"The Proteomics Protocols Handbook","first-page":"571","article-title":"Protein identification and analysis tools on the ExPASy server","author":"Gasteiger","year":"2005"},{"issue":"6","key":"10.1016\/j.ejps.2021.105837_bib0021","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1093\/bioinformatics\/btt619","article-title":"AllergenFP: allergenicity prediction by descriptor fingerprints","volume":"30","author":"Dimitrov","year":"2014","journal-title":"Bioinformatics"},{"issue":"6","key":"10.1016\/j.ejps.2021.105837_bib0022","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1007\/s00894-014-2278-5","article-title":"AllerTOP v. 2\u2014A server for in silico prediction of allergens","volume":"20","author":"Dimitrov","year":"2014","journal-title":"J. Mol. Model"},{"issue":"1","key":"10.1016\/j.ejps.2021.105837_bib0023","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-55613-w","article-title":"Designing a multi-epitopic vaccine against the enterotoxigenic Bacteroides fragilis based on immunoinformatics approach","volume":"9","author":"Majid","year":"2019","journal-title":"Sci. Rep."},{"issue":"19","key":"10.1016\/j.ejps.2021.105837_bib0024","doi-asserted-by":"crossref","first-page":"3098","DOI":"10.1093\/bioinformatics\/btx345","article-title":"Protein\u2013Sol: a web tool for predicting protein solubility from sequence","volume":"33","author":"Hebditch","year":"2017","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ejps.2021.105837_bib0025","series-title":"Methods in Enzymology","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/S0076-6879(96)66034-0","article-title":"GOR method for predicting protein secondary structure from amino acid sequence","author":"Garnier","year":"1996"},{"issue":"W1","key":"10.1016\/j.ejps.2021.105837_bib0026","doi-asserted-by":"crossref","first-page":"W402","DOI":"10.1093\/nar\/gkz297","article-title":"The PSIPRED protein analysis workbench: 20 years on","volume":"47","author":"Buchan","year":"2019","journal-title":"Nucleic Acids Res."},{"issue":"W1","key":"10.1016\/j.ejps.2021.105837_bib0027","doi-asserted-by":"crossref","first-page":"W384","DOI":"10.1093\/nar\/gkt458","article-title":"GalaxyRefine: protein structure refinement driven by side-chain repacking","volume":"41","author":"Heo","year":"2013","journal-title":"Nucleic acids res"},{"issue":"9","key":"10.1016\/j.ejps.2021.105837_bib0028","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1002\/pro.5560020916","article-title":"Verification of protein structures: patterns of nonbonded atomic interactions","volume":"2","author":"Colovos","year":"1993","journal-title":"Protein sci."},{"issue":"suppl_2","key":"10.1016\/j.ejps.2021.105837_bib0029","doi-asserted-by":"crossref","first-page":"W407","DOI":"10.1093\/nar\/gkm290","article-title":"ProSA-web: interactive web service for the recognition of errors in three-dimensional structures of proteins","volume":"35","author":"Wiederstein","year":"2007","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.ejps.2021.105837_bib0030","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1186\/1471-2105-9-514","article-title":"ElliPro: a new structure-based tool for the prediction of antibody epitopes","volume":"9","author":"Ponomarenko","year":"2008","journal-title":"BMC Bioinformatics"},{"issue":"1","key":"10.1016\/j.ejps.2021.105837_bib0031","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2105-14-S19-S1","article-title":"Disulfide by Design 2.0: a web-based tool for disulfide engineering in proteins","volume":"14","author":"Craig","year":"2013","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.ejps.2021.105837_bib0032","doi-asserted-by":"crossref","DOI":"10.1016\/j.imu.2020.100464","article-title":"Multi-epitope vaccine against cystic echinococcosis using immunodominant epitopes from EgA31 and EgG1Y162 antigens","volume":"21","author":"Nourmohammadi","year":"2020","journal-title":"Inform. Medicine Unlocked"},{"issue":"suppl_2","key":"10.1016\/j.ejps.2021.105837_bib0033","doi-asserted-by":"crossref","first-page":"W526","DOI":"10.1093\/nar\/gki376","article-title":"JCat: a novel tool to adapt codon usage of a target gene to its potential expression host","volume":"33","author":"Grote","year":"2005","journal-title":"Nucleic Acids Res."},{"issue":"4","key":"10.1016\/j.ejps.2021.105837_bib0034","doi-asserted-by":"crossref","first-page":"e9862","DOI":"10.1371\/journal.pone.0009862","article-title":"Computational immunology meets bioinformatics: the use of prediction tools for molecular binding in the simulation of the immune system","volume":"5","author":"Rapin","year":"2010","journal-title":"PLoS ONE"},{"issue":"11","key":"10.1016\/j.ejps.2021.105837_bib0035","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1017\/S0031182014000481","article-title":"Veterinary vaccines against toxoplasmosis","volume":"141","author":"HISZCZY\u0143SKA-SAWICKA","year":"2014","journal-title":"Parasitology"},{"issue":"3","key":"10.1016\/j.ejps.2021.105837_bib0036","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1080\/14712598.2018.1413086","article-title":"Moving towards improved vaccines for Toxoplasma gondii","volume":"18","author":"Li","year":"2018","journal-title":"Expert Opin Biol Ther"},{"issue":"12","key":"10.1016\/j.ejps.2021.105837_bib0037","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1586\/14760584.2015.1098539","article-title":"Recent advances in developing vaccines against Toxoplasma gondii: an update","volume":"14","author":"Zhang","year":"2015","journal-title":"Expert Rev. Vaccines"},{"issue":"12","key":"10.1016\/j.ejps.2021.105837_bib0038","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1080\/14789450.2016.1252675","article-title":"Immunomic approaches for antigen discovery of human parasites","volume":"13","author":"Kassegne","year":"2016","journal-title":"Expert Rev. Proteomics"},{"issue":"9","key":"10.1016\/j.ejps.2021.105837_bib0039","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1172\/JCI38330","article-title":"Vaccinology in the genome era","volume":"119","author":"Rinaudo","year":"2009","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.ejps.2021.105837_bib0040","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.immuni.2010.09.017","article-title":"Reverse vaccinology: developing vaccines in the era of genomics","volume":"33","author":"Sette","year":"2010","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.ejps.2021.105837_bib0041","doi-asserted-by":"crossref","first-page":"174","DOI":"10.5455\/javar.2019.f329","article-title":"Epitope-based vaccine as a universal vaccination strategy against Toxoplasma gondii infection: a mini-review","volume":"6","author":"Hajissa","year":"2019","journal-title":"J. adv. veterinary and animal res."},{"issue":"12","key":"10.1016\/j.ejps.2021.105837_bib0042","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-019-0353-9","article-title":"Innate, adaptive, and cell-autonomous immunity against Toxoplasma gondii infection","volume":"51","author":"Sasai","year":"2019","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.ejps.2021.105837_bib0043","doi-asserted-by":"crossref","first-page":"e6185","DOI":"10.7717\/peerj.6185","article-title":"Application of built-in adjuvants for epitope-based vaccines","volume":"6","author":"Lei","year":"2019","journal-title":"PeerJ."},{"issue":"34","key":"10.1016\/j.ejps.2021.105837_bib0044","doi-asserted-by":"crossref","first-page":"12294","DOI":"10.1073\/pnas.1400478111","article-title":"Unleashing the potential of NOD-and Toll-like agonists as vaccine adjuvants","volume":"111","author":"Maisonneuve","year":"2014","journal-title":"Proc. Nat. Acad. Sci."},{"issue":"2","key":"10.1016\/j.ejps.2021.105837_bib0045","doi-asserted-by":"crossref","first-page":"e30839","DOI":"10.1371\/journal.pone.0030839","article-title":"Synthetic Toll like receptor-4 (TLR-4) agonist peptides as a novel class of adjuvants","volume":"7","author":"Shanmugam","year":"2012","journal-title":"PLoS ONE"},{"issue":"10","key":"10.1016\/j.ejps.2021.105837_bib0046","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/j.addr.2012.09.039","article-title":"Fusion protein linkers: property, design and functionality","volume":"65","author":"Chen","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"3","key":"10.1016\/j.ejps.2021.105837_bib0047","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.0300-9475.2004.01442.x","article-title":"Epitope DNA vaccines against tuberculosis: spacers and ubiquitin modulates cellular immune responses elicited by epitope DNA vaccine","volume":"60","author":"Wang","year":"2004","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.ejps.2021.105837_bib0048","first-page":"1","article-title":"Designing a novel multiepitope peptide vaccine against melanoma using immunoinformatics approach","author":"Yazdani","year":"2020","journal-title":"J. Biomol. Struc. Dyn."},{"issue":"8","key":"10.1016\/j.ejps.2021.105837_bib0049","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1093\/protein\/14.8.529","article-title":"Design of the linkers which effectively separate domains of a bifunctional fusion protein","volume":"14","author":"Arai","year":"2001","journal-title":"Protein Eng."},{"key":"10.1016\/j.ejps.2021.105837_bib0050","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2020.607198","article-title":"Key limitations and new insights into the toxoplasma gondii parasite stage switching for future vaccine development in human, livestock, and cats","volume":"10","author":"M\u00e9v\u00e9lec","year":"2020","journal-title":"Front Cell Infect. Microbiol."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098721001391?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098721001391?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T12:00:27Z","timestamp":1760529627000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098721001391"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":50,"alternative-id":["S0928098721001391"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2021.105837","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of a chimeric vaccine candidate based on Toxoplasma gondii major surface antigen 1 and apicoplast proteins using comprehensive immunoinformatics approaches","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2021.105837","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105837"}}